109
Views
0
CrossRef citations to date
0
Altmetric
Editorial

The Impact of Gabapentinoid and Opioid Prescribing Practices on Drug Deaths: An Epidemiological Perspective

ORCID Icon, ORCID Icon & ORCID Icon
Pages 397-400 | Received 10 Dec 2021, Accepted 31 Jan 2022, Published online: 14 Feb 2022
 

Financial & competing interests disclosure

BH Smith is a member of the Scottish Government’s Short Life Working Group on Prescription Medicine Dependence and Withdrawal and is Chronic Pain Specialty Adviser to the Chief Medical Officer. BH Smith and LA Colvin led the revision of the SIGN Guideline 136 Management of Chronic Pain in 2019 (reference [Citation9]). LA Colvin is a member of the Scottish Government’s Short Life Working Group on Prescription Medicine Dependence and Withdrawal, is Vice Chair of the SIGN Council and is a Member of the MHRA Opioid Expert Working Group. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.